{"DataElement":{"publicId":"2951007","version":"1","preferredName":"Patient Negative Pregnancy Test Ind-4","preferredDefinition":"the indicator for eligibility with values of yes, no, unknown, or not applicable relating to a negative pregnancy test for a patient.","longName":"PT_NEG_PREGTEST_IND4","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2201733","version":"1","preferredName":"Patient Negative Pregnancy Test","preferredDefinition":"information relating to a negative pregnancy test for a patient.","longName":"PT_NEGATIVE_PREGTEST","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177068","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"Patient","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AB6-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207514","version":"1","preferredName":"Negative Pregnancy test","preferredDefinition":"Negative; involving disadvantage or harm.:Tests to determine whether or not an individual is pregnant.","longName":"C25247:C0032976","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative","conceptCode":"C25247","definition":"Involving disadvantage or harm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pregnancy test","conceptCode":"C0032976","definition":"Tests to determine whether or not an individual is pregnant.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2697-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2C45BCA-71CD-7026-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-23","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-03-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506035","version":"1","preferredName":"Yes No Unknown Not Applicable Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.","longName":"YES_NO_UNKNOWN_NA_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"14","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D41-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3241403","version":"1","preferredName":"Unknown","longName":"3241403","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4499CFB-7A3A-DD4D-E040-BB89AD4307BF","latestVersionIndicator":"Yes","beginDate":"2011-05-27","endDate":null,"createdBy":"DWARZEL","dateCreated":"2011-05-27","modifiedBy":"MMADDINENI","dateModified":"2023-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D4B-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D55-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Not Applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"3261243","version":"1","preferredName":"Not Applicable","longName":"3261243","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2BBD66-6581-A6F2-E040-BB89AD4311D3","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-08-10","modifiedBy":"RAGUNATHANU","dateModified":"2024-02-05","changeDescription":"12/15/15 added N/A as alternate VM-tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D5F-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2694968","version":"1","preferredName":"Ind-4","preferredDefinition":"A response or indicator that can have a value of yes, no, unknown, or not applicable.","longName":"C49486","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes, No, Unknown, or Not Applicable Response","conceptCode":"C49486","definition":"A response or indicator that can have a value of yes, no, unknown, or not applicable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"3EBCAFD6-ECF0-4640-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2007-11-12","endDate":"2016-04-27","createdBy":"CURTIST","dateCreated":"2007-11-12","modifiedBy":"TAYLORT","dateModified":"2020-10-02","changeDescription":"10.2.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Retired DBW 04-27-2016 requested By Tina Taylor approved by Dianne Reeves","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C379D9D0-6D2D-CCDD-E040-BB89AD432590","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"COOPERM","dateModified":"2020-08-13","changeDescription":"3/12/17 jk added Standard reg status; ownership  transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. 3/23/16 jk value \"Not evaluable\" added in error by COG on 3/21/16 was removed.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811908","version":"1","longName":"Gynecologic","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104894","version":"1","longName":"GOG-0231D","context":"NRG"},{"publicId":"4104903","version":"1","longName":"GOG-0170R","context":"NRG"},{"publicId":"10000427","version":"1","longName":"GOG-0170R","context":"NRG"},{"publicId":"10000426","version":"1","longName":"GOG-0170R","context":"NRG"},{"publicId":"10000172","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4104913","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4104890","version":"1","longName":"GOG-0229L","context":"NRG"},{"publicId":"4104881","version":"1","longName":"GOG-0227G","context":"NRG"},{"publicId":"4104893","version":"1","longName":"GOG-0230D","context":"NRG"},{"publicId":"4104897","version":"1","longName":"GOG-0250","context":"NRG"},{"publicId":"4104889","version":"1","longName":"GOG-0229K","context":"NRG"},{"publicId":"10000078","version":"1","longName":"GOG-0186H","context":"NRG"},{"publicId":"10000077","version":"1","longName":"GOG-0186H","context":"NRG"},{"publicId":"4104904","version":"1","longName":"GOG-0186H","context":"NRG"},{"publicId":"10000081","version":"1","longName":"GOG-0186J","context":"NRG"},{"publicId":"4104906","version":"1","longName":"GOG-0186J","context":"NRG"},{"publicId":"10000082","version":"1","longName":"GOG-0186J","context":"NRG"},{"publicId":"10000501","version":"1","longName":"GOG-0170Q","context":"NRG"},{"publicId":"4104902","version":"1","longName":"GOG-0170Q","context":"NRG"},{"publicId":"10000430","version":"1","longName":"GOG-0186I","context":"NRG"},{"publicId":"10000502","version":"1","longName":"GOG-0170Q","context":"NRG"},{"publicId":"10000429","version":"1","longName":"GOG-0186I","context":"NRG"},{"publicId":"4104905","version":"1","longName":"GOG-0186I","context":"NRG"},{"publicId":"10000346","version":"1","longName":"GOG-0186K","context":"NRG"},{"publicId":"10000345","version":"1","longName":"GOG-0186K","context":"NRG"},{"publicId":"4104907","version":"1","longName":"GOG-0186K","context":"NRG"},{"publicId":"4104891","version":"1","longName":"GOG-0229N","context":"NRG"},{"publicId":"10000281","version":"1","longName":"GOG-0280","context":"NRG"},{"publicId":"10000282","version":"1","longName":"GOG-0280","context":"NRG"},{"publicId":"4104929","version":"1","longName":"GOG-0280","context":"NRG"},{"publicId":"4104941","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"10000705","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"10000276","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104930","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"10000275","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104899","version":"1","longName":"GOG-0261","context":"NRG"},{"publicId":"4104886","version":"1","longName":"GOG-0265","context":"NRG"},{"publicId":"4104938","version":"1","longName":"GOG-0254","context":"NRG"},{"publicId":"4104940","version":"1","longName":"GOG-0268","context":"NRG"},{"publicId":"4104892","version":"1","longName":"GOG-0229O","context":"NRG"},{"publicId":"4104915","version":"1","longName":"GOG-0255","context":"NRG"},{"publicId":"10000592","version":"1","longName":"GOG-0255","context":"NRG"},{"publicId":"10000591","version":"1","longName":"GOG-0255","context":"NRG"},{"publicId":"4104939","version":"1","longName":"GOG-0264","context":"NRG"}]}],"AlternateNames":[{"name":"GOG","type":"USED_BY","context":"NRG"},{"name":"Theradex","type":"USED_BY","context":"Theradex"},{"name":"PT_NEG_PREGTEST_IND4","type":"USED_BY","context":"NRG"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"PT_NEG_PREGTEST_IND4","type":"USED_BY","context":"CCTG"},{"name":"IE_IEORRES_PREG","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"CRF Text3","type":"Alternate Question Text","description":"If the patient is of childbearing potential will she have a serum pregnancy test within 72 hours of starting protocol therapy and has she agreed to practice an effective form of birth control during study treatment and for six months after completion of treatment?","url":null,"context":"CTEP"},{"name":"If the patient is of childbea","type":"Preferred Question Text","description":"If the patient is of childbearing potential, has she had a negative serum pregnancy test within 72 hours prior to initiating protocol therapy and is she practicing an effective form of contraception","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative serum pregancy test and been practicing an effective form of contraception","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"If the patient has childbearing potential, has she had a negative serum pregnancy test within 14 days prior to initiation protocol therapy","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"If the patient has childbearing potential, has she had a negative serum pregnancy test performed 48 hours prior to study entry?","url":null,"context":"CTEP"},{"name":"CRF Text6","type":"Alternate Question Text","description":"If patient is of childbearing potential, has she had a negative serum pregnancy test within 14 days prior to study entry and agreed to practice an effective means of contraception during study treatment? ","url":null,"context":"CTEP"},{"name":"CRF Text7","type":"Alternate Question Text","description":"If the patient is of childbearing potential, did she have a negative pregnancy test prior to the study entry and has she agreed to use an effective form of contraception?","url":null,"context":"CTEP"},{"name":"CRF Text9","type":"Alternate Question Text","description":"If patient is of childbearing potential, has she had a negative serum pregnancy test within 14 days prior to initiating protocol therapy and agreed to practice an effective means of contraception during protocol therapy?","url":null,"context":"CTEP"},{"name":"CRF Text8","type":"Alternate Question Text","description":"If patient is of childbearing potential, will she have a negative serum pregnancy test within 72 hours prior to initiating protocol therapy and agreed to practice an effective means of contraception during study treatment?","url":null,"context":"CTEP"},{"name":"CRF Text13","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative pregnancy test and has she agree to practice an effective means of birth control prior to study entry, for the duration of study participation, and for four weeks after dosing with trametinib ceases?","url":null,"context":"CTEP"},{"name":"CRF Text10","type":"Alternate Question Text","description":"If patient is of childbearing potential, has she had a negative pregnancy test within 72 hours of initiating protocol therapy and has she agreed to use contraceptive measures during the study and for at least 3 months after completion of therapy?","url":null,"context":"CTEP"},{"name":"CRF Text12","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative serum pregnancy test within 14 days prior to randomization and has she agreed to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation?","url":null,"context":"CTEP"},{"name":"CRF Text11","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative serum pregnancy test within 48 hours prior to enrolling in this study and agreed to practice an effective means of contraception?","url":null,"context":"CTEP"},{"name":"CRF Text 16","type":"Alternate Question Text","description":"If the patient is of childbearing potential,has she had a negative pregnancy test within 14 days prior to study entry?","url":null,"context":"CTEP"},{"name":"CRF Text15","type":"Alternate Question Text","description":"If female of childbearing potential, is pregnancy test (sensitivity of at least 25mlU/mL) performed before first dose of ibrutinub and twice before initiation of lenalidomide, negative?","url":null,"context":"CTEP"},{"name":"GOG_CRF Text","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative pregnancy test and has she agree to practice an effective means of birth control prior to study entry, for the duration of study participation, and for four months after dosing with trametinib ceases?","url":null,"context":"NRG"},{"name":"CRF Text14","type":"Alternate Question Text","description":"If female of childbearing potential, does patient commit to continued abstinence from heterosexual intercourse or begin TWO acceptable methods of birth control: one highly effective method and one additional effective method AT THE SAME TIME, at least 28 days before starting lenalidomide?","url":null,"context":"CTEP"},{"name":"NRG_CRF Text","type":"Alternate Question Text","description":"If patient is of childbearing potential, has she had a negative serum pregnancy test within 72 hours prior to initiating protocol therapy and has she agreed to use adequate contraception (barrier method of birth control; abstinence) prior to study entry and for the duration of study participation and for 3 months after completion of therapy?","url":null,"context":"NRG"},{"name":"CRF Text 17","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative pregnancy test within 14 days prior to step 2 registration?","url":null,"context":"NRG"},{"name":"CRF Text 18","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative serum pregnancy test performed within 72 hours prior to registration?","url":null,"context":"NRG"},{"name":"Theradex Question","type":"Alternate Question Text","description":"If patient is woman of childbearing potential, is serum or urine pregnancy test done within 72 hours before the start of investigational product, negative?","url":null,"context":"Theradex"},{"name":"NRG_CRF Text 2","type":"Alternate Question Text","description":"If yes, has she had a negative serum pregnancy test within 14 days prior to study entry?","url":null,"context":"NRG"},{"name":"CRF Text21","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative pregnancy test within 7 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG_CRF text5","type":"Alternate Question Text","description":"If patient is of childbearing potential, has she had a negative serum pregnancy test within 14 days prior to registration and has she agreed to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 23 weeks after the last dose of investigational drug?","url":null,"context":"NRG"},{"name":"NRG_CRF text 6","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative pregnancy test within 14 days prior to randomization and has she agreed to use a highly effective method of contraception (e.g. hormonal,intrauterine device or abstinence; Abstinence is only acceptable when this is in line with the preferred and usual lifestyle of the patient) prior to study entry, for the duration of study participation, and for six months after the last dose of study treatment?","url":null,"context":"NRG"},{"name":"NRG_CRF Text 3","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative serum pregnancy test within 14 days prior to randomization and has she agreed to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation, and for four months after the last dose of study treatment?","url":null,"context":"NRG"},{"name":"CRF Text 20","type":"Alternate Question Text","description":"Females of childbearing potential must have a negative urine or serum pregnancy test within 72 hours before receiving the first dose of study medication. If not a woman of childbearing potential or a male, please check N/A","url":null,"context":"CTEP"},{"name":"NRG_CRF Text 4","type":"Alternate Question Text","description":"If the patient is of childbearing potential, did she have a negative pregnancy test prior to screening and is she willing and able to use medically acceptable forms of contraception during the trial?","url":null,"context":"NRG"},{"name":"CRF TEXT_25","type":"Alternate Question Text","description":"Was a negative pregnancy test obtained prior to the treatment cycle","url":null,"context":"NRG"},{"name":"CRF TEXT22","type":"Alternate Question Text","description":"Was a negative pregnancy test performed prior to the treatment  cycle","url":null,"context":"NRG"},{"name":"CRF TExt 30","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative pregnancy test within 28 days prior to step 2 registration?","url":null,"context":"NRG"},{"name":"eligibility question","type":"Alternate Question Text","description":"If patient is of childbearing potential, has she had a negative serum pregnancy test within 28 days prior to initiating protocol therapy and has she agreed to use two reliable forms of contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation and for 6 weeks after completion of therapy?","url":null,"context":"NRG"},{"name":"NRG_CRF text 7","type":"Alternate Question Text","description":"If patient is of child bearing potential, has the patient had a negative pregnancy test within 14 days prior to registration AND does the patient agree to use two reliable forms of contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for 3 months after the last dose of olaparib or 6 weeks after the last dose of cediranib?","url":null,"context":"NRG"},{"name":"PBTC_Text1","type":"Alternate Question Text","description":"Female patient of childbearing potential will have two pregnancy tests: once within 10 - 14 days prior to starting pomalidomide (can include the enrollment test) AND again within 24 hours prior to initiation of pomalidomide, and patient will only proceed with enrollment if both pregnancy tests are negative?","url":null,"context":"PBTC"},{"name":"CRF TEXT 31","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative serum pregnancy test within 14 days prior to step 2 registration?","url":null,"context":"NRG"},{"name":"NRG_CRF TEXT 8","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative pregnancy test within 14 days prior to step 2 registration?","url":null,"context":"NRG"},{"name":"NRG CRF_Text 10","type":"Alternate Question Text","description":"If the patient is of childbearing potential,has she had a negative pregnancy test within 7 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG_CRF Text9","type":"Alternate Question Text","description":"If patient is of child bearing potential, has she had a negative serum pregnancy test within 28 days prior to initiating protocol therapy has she agreed to use two reliable forms of contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation and as specified in the protocol after completion of therapy?","url":null,"context":"NRG"},{"name":"NRG_CRF Text 11","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative pregnancy test within 14 days prior to registration?","url":null,"context":"NRG"},{"name":"CRF Text 32","type":"Alternate Question Text","description":"Does she agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 5 months (150 days) after the last dose of atezolizumab, 6 months after the last dose of bevacizumab, and 6 months after the last dose of mFOLFOX6?","url":null,"context":"CTEP"},{"name":"CE7","type":"Alternate Question Text","description":"If a woman of child bearing potential (WOCBP), patient has had a negative serum or urine pregnancy test within 14 days prior to randomization.","url":null,"context":"CCTG"},{"name":"NRG_CRF Text12","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative pregnancy test within 24 hours prior to registration?","url":null,"context":"NRG"},{"name":"CRF TEXT 36","type":"Alternate Question Text","description":"If WOCBP, did the patient have a negative serum pregnancy test within 14 days prior to registration and agree to use a birth control method in addition to barrier methods (condoms or diaphragm) while receiving treatment with temozolomide","url":null,"context":"NRG"},{"name":"NRG_CRF TEXT 14","type":"Alternate Question Text","description":"If the patient is a woman of childbearing potential (WOCBP), is the serum or urine pregnancy test negative within 7 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG_CRF TEXT 13","type":"Alternate Question Text","description":"Has the woman of child bearing potential had a negative serum or urine pregnancy test within 42 days prior to registration.","url":null,"context":"NRG"},{"name":"CRF TEXT 37","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative pregnancy test within 72 hours prior to step 2 registration?","url":null,"context":"NRG"},{"name":"CRF TEXT 38","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative pregnancy test within 7 days prior to step 2 registration?","url":null,"context":"NRG"},{"name":"CRF TEXT 39","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative pregnancy test within 45 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG_CRF TEXT 40","type":"Alternate Question Text","description":"If the patient is of childbearing potential, has she had a negative urine or serum pregnancy test within less than or equal to 14 days prior to registration?","url":null,"context":"NRG"},{"name":"CCTG_01","type":"Alternate Question Text","description":"If a woman of child bearing potential (WOCBP), patient has had a negative serum or urine pregnancy test within 28 days prior to randomization.","url":null,"context":"CCTG"}],"origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"756F4BA4-B3D1-983B-E040-BB89AD432407","latestVersionIndicator":"Yes","beginDate":"2009-10-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-10-08","modifiedBy":"CLOHNES","dateModified":"2022-12-21","changeDescription":"Replaced VD Eligibility Ind-4 2774784v1 with VD ID#3506035 - Yes No Unknown Not \r\nApplicable Indicator - dbw\r\n03-20-2018 Fix PBCT_ Text1 to change upside down question mark to a hypen-minus DW","administrativeNotes":"12/21/22 added AQT for ticket number CADSR0001818 cjl.","unresolvedIssues":null,"deletedIndicator":"No"}}